RECURRENT PROSTATE CARCINOMA
Clinical trials for RECURRENT PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a deworming drug help fight prostate cancer?
Disease control CompletedThis early-stage trial tested a combination of two drugs—enzalutamide (a standard hormone therapy) and niclosamide (a drug used for worm infections)—in 6 men with advanced prostate cancer that no longer responds to hormone therapy. The goal was to find the safest dose and identif…
Matched conditions: RECURRENT PROSTATE CARCINOMA
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
Heat boosts radiation against returning prostate cancer in early trial
Disease control CompletedThis early study tested whether adding heat therapy (hyperthermia) to high-dose radiation is safe for men whose prostate cancer returned after previous radiation. Only 3 men took part, and the main goal was to see side effects. The approach aims to make cancer cells more sensitiv…
Matched conditions: RECURRENT PROSTATE CARCINOMA
Phase: NA • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 18, 2026 12:00 UTC
-
Focused radiation beams take aim at multiple tumors in early trial
Symptom relief CompletedThis early-stage study tested a precise, high-dose radiation technique called stereotactic body radiotherapy (SBRT) in 42 people with breast, lung, or prostate cancer that had spread to several places in the body. The main goal was to find the safest dose and check for side effec…
Matched conditions: RECURRENT PROSTATE CARCINOMA
Phase: PHASE1 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated May 26, 2026 09:34 UTC